The Pathophysiological Role of Renal Dopamine and Kallikrein in Deoxycorticosterone Acetate (DOCA)-Salt Treated Rats

References

• Cuche J. L., Kuchel O., Barbeau A., Boucher R., Genest J. Relationship between the adrenergic nervous system and renin during adaptation to upright posture: a possible role for 3,4-dihydroxyphenethylamine (dopamine). Clin Sci. 1972; 43: 481–491
   PubMed Web of Science ®Google Scholar
• Alexander R. W., Gill J. R., Jr., Yamabe H., Lovenberg W., Keiser H R. Effects of dietary sodium and acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest. 1974; 54: 194–200
   PubMed Web of Science ®Google Scholar
• Oates N. S., Ball S. G., Perkins C. M., Lee M. R. Plasma and urine dopamine in man given sodium chloride in the diet. Clin Sci. 1979; 56: 261–264
   PubMed Web of Science ®Google Scholar
• Kuchel O., Buu N. T., Unger T., Grnest J. Free and conjugated catecholamine in human hypertension. Clin Sci Mol Med. 1978; 55: 77s–80s
   Google Scholar
• Iimura O., Kikuchi K., Takigami Y., Mito T., Tsuzuki M., Shibata S. Enhanced natriuretic response to dopamine infusion in low renin essential hypertension. NZ Med J. 1983; 9: 860–863
   Google Scholar
• Iimura O., Yamaji I., Kikuchi K., Shibata S., Nishimura M., Nozawa A., Aoki K., Hasegawa T. T, Kobayakawa H., Komura H. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension. Jpn Circ J. 1987; 51: 1232–1240
   PubMedGoogle Scholar
• Aoki K., Kikuchi K., Yamaji I., Nishimura M., Honma C., Kobayakawa H., Yamamoto M., Kudoh C., Shimazaki M., Sakamoto T., Wada A., Iimura O. Attenuated renal production of dopamine in patients with low renin essential hypertension. Clin Exp Hypertens. 1989; A11(Suppl.1)403–409
   Google Scholar
• Herlitz H., Lundin S., Henning M., Aurell M., Karlberg B. E., Berglund G. Hormonal pattern during development of hypertension in spontaneously hypertensive rats (SHR). Clin Exp Hypertens. 1982; A4(6)915–935
   Google Scholar
• Kuchel O., Racz K., Buu N. T., Tenneson S. The adrenal synthesis and tissue content of dopamine increase when blood pressure rises in spontaneously hypertensive rats. J Hypertens. 1984; 2(Suppl 3)127–129
   PubMedGoogle Scholar
• Racz K., Kuchel O., Buu N. T. Abnormal adrenal catecholamine synthesis in salt-sensitive Dahl rats. Hypertension. 1987; 9: 76–80
   PubMed Web of Science ®Google Scholar
• Itskovitz H. D., Campbell W. B. Vasodilators, intrarenal distribution of blood flow and renal function in isolated perfused canine kidneys. Proc Soc Exp Biol Med. 1976; 153: 161–165
   PubMed Web of Science ®Google Scholar
• Stein H., Congbalay R. C., Karsh D. L., Osgood R. W., Ferris T. F. The effect of bradykinin on proximal tubular sodium reabsorption in the dog: Evidence for functional nephron heterogeneity. J Clin Invest. 1972; 51: 1709–1721
   PubMed Web of Science ®Google Scholar
• Shimamoto K., Ura N., Nakao T., Nishimiya T., Mita T., Kondo M., Ando T., Tanaka S., Iimura O. Role of the renal kallikrein-kinin system in sodium metabolism in normotensives and essential hypertensives. NZ Med J. 1983; 9: 905–907
   Google Scholar
• Seino M., Abe K., Otsuka Y, Saito T., Irokawa N., Yasujima M., Ciba S., Yoshinaga K. Urinary kallikrein excretion and sodium metabolism in hypertensive patients. Tohoku J Exp Med. 1975; 116: 359–367
   PubMed Web of Science ®Google Scholar
• de Champlain J., Farley L., Cousineau D., van Ameringen M. R. Circulating catecholamine levels in human and experimental hypertension. Circ Res. 1976; 38: 109–114
   PubMed Web of Science ®Google Scholar
• Chen Y., Nagahama S., Winternitz S. R. Oparil, S. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats. Am J Physiol. 1985; 249: H71–H79
   PubMed Web of Science ®Google Scholar
• Takeda K., Nakamura Y., Oguro M., Kawasaki S., Hayashi J., Tanabe S., Nakata T., Lee L. C., Sasaki S., Nakagawa M. Central attenuation of baroreflex precedes the development of hypertension in DOCA-salt-treated rats. Am J Hypertens. 1988; 1: 23s–25s
   PubMed Web of Science ®Google Scholar
• Tomiyama H., Scicli A. G., Scicli G. M., Carretero O. A. Renal effects of Fab fragments of kinin antibodies on Deoxycorticosterone acetate-salt-treated rats. Hypertension. 1990; 15: 761–766
   PubMed Web of Science ®Google Scholar
• Majima M., Katori M., Hanazuka M., Mizogami S., Nakano T., Nakao Y., Mikami R., Uryu H., Okamura R., Mohsin S. S. J., Oh-ishi S. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 1991; 17: 806–813
   PubMed Web of Science ®Google Scholar
• Maddedu P., Parpaglia P. P., Demontis M. P., Varoni M. V., Fattaccio M. C., Tonolo G., Troffa C., Glorioso N. Bradykinin B2-receptor blockade facilitates deoxycorticosterone-salt hypertension. Hypertension. 1993; 21: 980–984
   PubMed Web of Science ®Google Scholar
• Villamil M. F., Amorena C., Ponce-Hornos J., Muller A., Taquini A. C. Role of extracellular volume expansion in the development of DOC-salt hypertension in rat. Hypertension 1982; 4: 620–624
   PubMed Web of Science ®Google Scholar
• Trinder D., Phillips P. A., Risvanis J., Stephenson J. M., Johnston C. I. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Hypertension 1992; 20: 569–574
   PubMed Web of Science ®Google Scholar
• Li M., Martin A., Liu D. T., Whitworth J. A. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?. J Hypertens 1994; 12: 569–576
   PubMed Web of Science ®Google Scholar
• Lariviere R., Day R., Schiffrin E. L. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1993; 21: 916–920
   PubMed Web of Science ®Google Scholar
• Li J. S., Lariviere R., Schiffrin E. L. Effect of nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1994; 24: 183–188
   PubMed Web of Science ®Google Scholar
• Kissinger P. T., Riggins R. M., Alcorn R. L., Rau L. D. Estimation of catecholamines in urine by high performance liquid chromatography with electrochemical detection. Biochem Med. 1975; 13: 299–306
   PubMed Web of Science ®Google Scholar
• Nakagawa M., Shimamoto K., Kondo M., Ura N., Nishitani T., Ishida H., Yokoyama T., Tanaka S., Iimura O. Purification of human low molecular weight kininogen and its application for a simple and sensitive method for determination of human urinary kallikrein activity. Adv Exp Med Biol. 1986; 198B: 523–529
   Google Scholar
• Zimlichman R, Levinson P D, Kelly G, Stull R, Keiser H R, Goldstein D S. Derivation of urinary dopamine from plasma dopa. Clin Sci 1988; 75: 515–520
   PubMed Web of Science ®Google Scholar
• Wolfovitz E, Grossman E, Folio C J, Keiser H R, Kopin I J, Goldstein D S. Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin Sci 1993; 84: 549–557
   PubMed Web of Science ®Google Scholar
• Ishiguro T., Shimamoto K., Sakamoto T., Hayashi M., Torii T., Iimura O. Renal dopaminergic activity in patients with primary aldosteronism. Hypertens Res. 1995, (in press)
   Google Scholar
• Bass A. S., Murphy M. B. Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion. Clin Exp Hypertens. 1991; A13(6&7)1127–1151
   Google Scholar
• Yoshimura M., Kambara S., Okabayashi H., Ikegaki I., Matsuzawa M., Suga K., Takahashi H., Ijichi H. Pathophysiological role of dopamine on the development of hypertension in rats. Jpn Circ J. 1987; 51: 1226–1231
   PubMedGoogle Scholar
• Kambara S., Yoshimura M., Okabayashi H., Takahashi H., Ijichi H. Attenuated development of hypertension by chronic administration of bromocriptine in DOCA-salt hypertensive rats. Jpn Circ J. 1986; 50: 1120–1127
   PubMedGoogle Scholar
• Dawson R., Jr, Oparil S. Renal catecholamine and alpha 2-adrenergic receptors in salt-related and genetic hypertension. Pharmacology. 1987; 34: 131–142
   PubMed Web of Science ®Google Scholar
• Nustad K., Vaaje K., Pierce J. V. Synthesis of kallikreins by rat kidney slices. Br J Pharmacol 1975; 53: 229–234
   PubMed Web of Science ®Google Scholar
• Omata K., Carretero O. A., Scicli A. G., Jackson B. A. Localization of active and inactive kallikrein (kininogenase activity) in the microdissected rabit nephron. Kidney Int. 1982; 22: 602–607
   PubMed Web of Science ®Google Scholar
• Imai M. The connecting tubule: a functional subdivision of the rabit distal nephron segments. Kidney Int. 1979; 15: 346–356
   PubMed Web of Science ®Google Scholar
• Geller R. G., Margolius H. S., Pisano J. J., Keiser H. R. Effects of mineralocorticoids, altered sodium intake, adrenalectomy on urinary kallikrein in rats. Circ Res. 1972; 31: 857–861
   PubMed Web of Science ®Google Scholar
• Margolius H. S., Geller R. G., Pisano J. J., Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet. 1971; 13: 1063–1065
   Google Scholar
• Holland O. B., Chud J. M., Braunstein H. Urinary kallikrein excretion in essential and mineralocorticoid hypertension. J Clin Invest. 1980; 65: 347–356
   PubMed Web of Science ®Google Scholar